1,796 material Form 8-K filings that 1,448 companies we cover made with the SEC in May 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Data Storage Corp entered into an Equity Distribution Agreement with Maxim Group LLC on May 26, 2026, allowing it to sell common stock through Maxim over time. The ATM Prospectus covers up to $10,600,000 of shares, and the company is not obligated to sell any shares, so the deal could dilute existing shareholders if sales occur.
Agreement dated May 26, 2026 with Maxim Group LLC; Maxim earns a 2.5% commission on gross proceeds from each share sale.
ATM Prospectus relates to up to $10,600,000 of common stock under shelf registration Form S-3 (File 333-280881), declared effective July 26, 2024.
Company must pay up to $25,000 in specified expenses plus $2,500 in legal fees for Maxim on each Bringdown Date.
The company is not required to sell any shares, and the filing gives no assurance on sale timing, price or amount.
Burtech Acquisition Corp II, a Cayman Islands blank check company, closed its initial public offering of 8,000,000 units at $10.00 per unit on May 26, 2026, for gross proceeds of $80,000,000. A total of $80,400,000 was placed in a trust account, and the funds will not be released until the company completes an initial business combination, redeems public shares, or liquidates.
IPO closed May 26, 2026: 8,000,000 units at $10.00 per unit, gross proceeds of $80,000,000.
$80,400,000 placed in a trust account maintained by Continental Stock Transfer & Trust Company.
Sponsor and third-party investors bought 252,000 private placement units at $10.00 for $2,520,000.
Company has 15 months from the IPO closing to complete a business combination, extendable up to 21 months; four directors were appointed May 21, 2026.
Lincoln International, Inc. and its selling stockholders completed the initial public offering of 24,207,486 Class A common shares at $20.00 per share on May 21, 2026, including 3,157,498 shares from the underwriters' option. The company received gross proceeds of $473.7 million before underwriting discounts and commissions, and the filing says its charter and bylaws became effective on May 19, 2026.
Offering of 24,207,486 Class A shares at $20.00 per share, completed May 21, 2026, including 3,157,498 shares from the underwriters' option
Gross proceeds to the company of $473.7 million, before underwriting discounts and commissions
M. Christie Smith and John W. Oleniczak appointed to the board effective May 19, 2026
Charter authorizes 650,000,000 Class A, 250,000,000 Class B, 100,000,000 Class C and 5,000,000 preferred shares
The fund sold $50 million of Series A Mandatorily Redeemable Preferred Shares due April 30, 2031, and agreed to sell $40 million of 5.364% Series C Senior Notes due July 8, 2030. Proceeds will mainly refinance existing debt, including redeeming 2.35% Series A Senior Notes maturing July 8, 2026, and fund new portfolio investments; the preferred holder gains the right to elect two trustees.
Series A preferred: 2,000,000 shares at $25.00 liquidation preference, $50 million gross proceeds, due April 30, 2031
Series C Senior Notes: $40 million at a fixed 5.364% rate, maturing July 8, 2030, with proceeds used to redeem 2.35% Series A Senior Notes maturing July 8, 2026
Preferred purchaser may elect two trustees; Ira P. Cohen nominated as a Class III Trustee
Annual shareholder meeting set for September 25, 2026; record date July 10, 2026
Editas Medicine agreed to sell 55,555,556 shares of common stock, each paired with a common stock warrant, at a combined price of $2.25, with net proceeds estimated at $117.0 million. The company said the proceeds, together with its cash as of March 31, 2026, should fund operations into the second half of 2028, and the warrants could add about $192.5 million if fully exercised for cash, which would also dilute existing holders.
Gross offering size of about $125.0 million before underwriting discounts and offering expenses, with closing expected on or about May 27, 2026
Cash runway extended to the second half of 2028, based on current plans and assumptions the company says may prove wrong
Warrants have a $3.50 per share exercise price and expire on the earlier of 30 days after Phase 1 EDIT-401 data showing at least three patients with greater than 80% LDL-cholesterol reduction, or three years from issuance
Starwood Property Trust closed a private offering of $600 million in 6.125% unsecured senior notes due June 1, 2031, on May 26, 2026. The company intends to use the net proceeds for eligible green and social projects and, pending that allocation, to redeem $400 million of 3.625% notes due 2026 and for general corporate purposes. The new debt adds to the company's obligations, while the refinancing would replace notes maturing in 2026.
Principal amount of $600 million, priced May 11, 2026, closed May 26, 2026
Interest at 6.125% per year, paid semi-annually on June 1 and December 1, starting December 1, 2026
Proceeds may repay $400 million of 3.625% Senior Notes due 2026 and outstanding repurchase facility debt
Notes are unsecured, not guaranteed by subsidiaries at issuance, with a covenant requiring Total Unencumbered Assets of at least 120% of unsecured debt
On May 22, 2026, World Acceptance entered into a Consent and Limited Modification with Bank of Montreal, as administrative agent, and the Required Lenders under its July 22, 2025 revolving credit agreement. The modification temporarily lowers the minimum fixed charge ratio for three quarters, and the original 2.25 to 1.0 requirement returns for the quarter ending December 31, 2026. The filing does not state the reason for the modification.
Modified minimum ratio: 2.20 to 1.0 for the quarter ending March 31, 2026; 2.10 to 1.0 for June 30, 2026; and 2.15 to 1.0 for September 30, 2026
Original requirement of not less than 2.25 to 1.0 resumes for the quarter ending December 31, 2026
Agreement dated May 22, 2026, with Bank of Montreal as administrative agent and collateral agent
All other terms of the credit agreement remain in full force
Shimmick Corporation sold 4,289,500 common shares at $3.50 each in an underwritten public offering led by Roth Capital Partners, after the underwriter exercised its full option to buy 559,500 additional shares. The company received net proceeds of approximately $14.0 million after the underwriting discount and estimated offering expenses, and the offering closed on May 26, 2026. New shares increase the number outstanding, so existing holders' ownership percentage is reduced, while the company gains cash.
Offering agreement with Roth Capital Partners, LLC dated May 22, 2026; public offering price $3.50 per share
Total shares sold 4,289,500, including 559,500 shares from the underwriter's option
Net proceeds of approximately $14.0 million; offering closed May 26, 2026
Sold under a Form S-3 shelf registration declared effective July 10, 2025
On May 26, 2026, Florida Power & Light Company, NextEra Energy's utility subsidiary, sold $255,394,000 principal amount of Floating Rate Notes due June 1, 2076. The filing is administrative: it reports the sale and files legal opinions from two law firms as exhibits, and it does not describe any change to the company's results or outlook.
Principal amount sold: $255,394,000 on May 26, 2026
Interest rate: Compounded SOFR minus 0.35%, calculated quarterly
Notes registered under Registration Statement Nos. 333-278184, 333-278184-01 and 333-278184-02
Exhibits filed: legal opinions from Squire Patton Boggs (US) LLP and Morgan, Lewis & Bockius LLP, both dated May 26, 2026
Urban Outfitters and certain domestic subsidiaries signed a fifth amendment on May 19, 2026 to its asset-based revolving credit facility. The amendment extends the facility's maturity to May 2031 and removes the Canadian sub-facility, with its Canadian subsidiary released from obligations under the facility.
Facility continues to provide loans and letters of credit up to $350 million, subject to a borrowing base of eligible accounts receivable and inventory
Maturity date extended to May 2031
Canadian Borrowing Base and Canadian Sublimit removed; URBN Canada Retail, Inc. released from its obligations under the facility
Obligations remain unconditionally guaranteed by the Company and certain U.S. subsidiaries and secured by first-priority interest in inventory, accounts receivable and certain other assets
Assembly Biosciences sold 3,358,602 common shares at $26.50 each and pre-funded warrants for up to 415,000 shares, and underwriters exercised in full a 566,040-share option on May 22, 2026. The offering closed on May 26, 2026, with the company reporting net proceeds of approximately $107.4 million. The company plans to use the proceeds for clinical development of pipeline candidates and general corporate purposes, and the new shares increase the number of shares outstanding for existing shareholders.
Closed May 26, 2026, including the full exercise of a 566,040-share underwriter option on May 22, 2026.
Common shares priced at $26.50; pre-funded warrants for up to 415,000 shares priced at $26.499 each.
Gross proceeds of approximately $115.0 million; net proceeds of approximately $107.4 million after underwriting discounts and offering expenses.
Executive officers and directors agreed to a 90-day lock-up, subject to exceptions and Guggenheim Securities' consent to sell.
Lamb Weston's Chinese subsidiary, LW Ulanqab, entered into a RMB 700 million term loan facility with HSBC Bank (China) on May 19, 2026, maturing May 22, 2031. The loan repaid and replaced its 2022 facility, which was terminated May 22, 2026, and the parent company guarantees the obligations. The filing reports refinancing of existing debt rather than a new borrowing for other uses, and it does not disclose any earnings or guidance changes.
Term loan of RMB 700 million, about $102.94 million at the May 19, 2026 exchange rate, maturing May 22, 2031
Interest at the five-year prime rate published by the PRC National Interbank Funding Center plus 0.30%
Amortization payments begin 6 months after the initial borrowing, with the remaining principal due at maturity
The 2022 Facility Agreement dated February 18, 2022 was repaid and terminated on May 22, 2026
AmeriGas Partners and AmeriGas Finance Corp., indirect wholly owned subsidiaries of UGI, issued $500.0 million of 6.875% senior unsecured notes due 2031 on May 20, 2026. The proceeds, with other funds, are being used to redeem the 2027 notes, repurchase up to $175.0 million of 9.375% notes due 2028, and repay $150.0 million of an intercompany loan. The filing shows a new debt issue replacing or reducing existing higher-cost debt, with the company reporting no earnings impact.
$500.0 million of 6.875% senior unsecured notes due 2031 issued May 20, 2026; semi-annual interest begins December 1, 2026
Holders tendered $468,471,000 of 2027 notes; remaining 2027 notes to be redeemed June 10, 2026
$224,771,000 of 2028 notes tendered by the May 22, 2026 early deadline against a $175.0 million cap; proration factor about 77.9%
Initial settlement for accepted 2028 notes set for May 27, 2026 at $1,023.44 per $1,000 principal
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.